To assess the genome-wide effects of reduced EZH2 on H3K27 methylation, we performed a ChIP-on-ChIP analysis in MDS primary CD34+ cells from eight patients with MDS and eight normal controls. The gene discussed is EZH2; the disease is myelodysplastic syndrome.